US Health Agency Unveils Ambitious 24/7 AI for Cardiovascular Care

The US Advanced Research Projects Agency for Health has launched the ADVOCATE program to create an FDA-authorized AI agent for continuous cardiovascular care. This revolutionary AI aims to schedule appointments, adjust medications, and monitor wearables. It seeks to enhance patient access but faces regulatory hurdles regarding liability and safety. The program is set for a three-year approval timeline, with an initial review in one year.